Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-9-1
pubmed:abstractText
Aurora-A, also known as Aik, BTAK, or STK15, is a centrosomal serine/threonine protein kinase, which is proto-oncogenic and is overexpressed in a wide range of human cancers. Besides gene amplification and mRNA overexpression, proteolytic resistance mechanisms are thought to contribute to overexpression of Aurora-A. However, it is not yet clear how overexpressed Aurora-A affects the expression of transformed phenotype. Here, we found that nuclear accumulation of Aurora-A was critical for transformation activity. Cellular protein fractionation experiments and immunoblot analysis demonstrated a predominance of Aurora-A in the nuclear soluble fraction in head and neck cancer cells. Indirect immunofluorescence using confocal laser microscopy confirmed nuclear Aurora-A in head and neck cancer cells, while most oral keratinocytes exhibited only centrosomal localization. The expression of nuclear export signal-fused Aurora-A demonstrated that the oncogenic transformation activity was lost on disruption of the nuclear localization. Thus, the cytoplasmic localization of overexpressed Aurora-A previously demonstrated by immunohistochemical analysis is not likely to correspond to that in intact cancer cells. This study identifies an alternative mode of Aurora-A overexpression in cancer, through nuclear rather than cytoplasmic functions. We suggest that substrates of Aurora-A in the cell nuclear soluble fraction can represent a novel therapeutic target for cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1098-2744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
810-20
pubmed:dateRevised
2011-7-11
pubmed:meshHeading
pubmed-meshheading:19204928-Animals, pubmed-meshheading:19204928-BALB 3T3 Cells, pubmed-meshheading:19204928-Cell Line, pubmed-meshheading:19204928-Cell Line, Tumor, pubmed-meshheading:19204928-Cell Nucleus, pubmed-meshheading:19204928-Cell Transformation, Neoplastic, pubmed-meshheading:19204928-Centrosome, pubmed-meshheading:19204928-Cytoplasm, pubmed-meshheading:19204928-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:19204928-Green Fluorescent Proteins, pubmed-meshheading:19204928-HeLa Cells, pubmed-meshheading:19204928-Head and Neck Neoplasms, pubmed-meshheading:19204928-Humans, pubmed-meshheading:19204928-Immunoblotting, pubmed-meshheading:19204928-Immunoprecipitation, pubmed-meshheading:19204928-Keratinocytes, pubmed-meshheading:19204928-Mice, pubmed-meshheading:19204928-Microscopy, Confocal, pubmed-meshheading:19204928-Polymorphism, Single Nucleotide, pubmed-meshheading:19204928-Protein-Serine-Threonine Kinases, pubmed-meshheading:19204928-RNA, Small Interfering, pubmed-meshheading:19204928-Recombinant Fusion Proteins, pubmed-meshheading:19204928-Transfection
pubmed:year
2009
pubmed:articleTitle
Oncogenic role of nuclear accumulated Aurora-A.
pubmed:affiliation
Department of Life Sciences, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, Hiroshima 727-0023, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't